Results 41 to 50 of about 13,855 (204)
Reversible biliary occlusion in a small animal model: first description of a new technique
Experimental models with reversible biliary occlusion resulted in a high mortality of the animals, up to 20–60% according to the literature. Our aim was to assess a safe and valid technique for reversible biliary occlusion with a low mortality.
Richter Beate +5 more
doaj +1 more source
Background: As the clinical value of cytokeratin-19 (CK19) and thymidine kinase-1 (TK1) in advanced gastrointestinal cancer remains controversial, we investigated their expression and clinical significance in this disease.
Ying-Ying Du +2 more
doaj +1 more source
Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid [PDF]
Papillary carcinoma of the thyroid (PTC) is the commonest thyroid cancer. In the recent decades an obvious increase in the incidence of PTC has occurred. The pathological diagnosis of PTC is usually an easy diagnosis in the majority of cases. However since the introduction of follicular variant of PTC and the wide threshold range in interpretation of ...
Alowami Salem +2 more
openaire +3 more sources
Prognostic significance of CD44 and CK19 expression in head and neck squamous cell carcinoma
Purpose of the study. To analyze and synthesize current scientific evidence on the role of CD44 and CK19 expression in the pathogenesis of head and neck squamous cell carcinoma (HNSCC), their diagnostic and prognostic significance, as well as their ...
Han Yuyao +8 more
doaj +1 more source
Background and objective: Papillary thyroid carcinoma (PTC) is the most common primary thyroid cancer. PTC diagnosis is based on the presence of classic nuclear features in most cases.
Tavga Hushair Dizeyi
doaj +1 more source
Angiogenesis and CK19 expression in papillary thyroid carcinoma
Purpose: Aim of the present study is to evaluate immunohistochemically the diagnostic value of CK19 in papillary thyroid carcinoma (PC) and to determine the microvascular density (MDV) in tumor tissue by CD34. Methods: We studied immunohistochemical expression of CK19 in both tumor tissue and adjacent non-tumor tissue of ten patients that had undergone
D. Malinova, M. Tzaneva
openaire +1 more source
CK19 and GPC3 expression in different histological variation of HCC.
Thin trabecular HCC was usually accompanied by the pseudoglandular structure (blue arrow head). This histological variant mostly showed CK19−/GPC3− expression (A). Majority of SHCCs showed CK19+/GPC3+ expression. But nearly half of CK19+/GPC3+ cases with
Hui Xia (133168) +10 more
core +1 more source
In humans, peripheral blood cytokeratin 19 (CK19) mRNA-positive circulating tumor cells (CTCs) was utilized to identify early-stage breast cancer patients with micrometastatic disease who are at risk for disease progression and monitor treatment response
Potsawat Tanvetthayanont +4 more
doaj +1 more source
Serum CK19-2G2 levels in breast cancer patients.
(A) The Mean of serum CK19-2G2 levels in healthy, benign, BC group. Serum CK19-2G2 levels in breast cancer patients are higher than those in the healthy and benign controls respectively.(BC vs Benign ...
Yanan Kong (384071) +14 more
core +1 more source
Validation of a screening platform to identify CK19+ cell mitogens.
A) Number of CK19+ cells at the end of the culture normalized to the number obtained in basal serum-free medium culture. B) Fraction of CK19+ cells that incorporated BrdU during the last day of culture, normalized to BrdU incorporation in basal medium ...
James M. Piret (176798) +2 more
core +1 more source

